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Abstract
The complexity of selenium (Se) chemistry in the environment and in living organisms presents broad analytical challenges. The selective
qualitative and quantitative determination of particular species of this element is vital in order to understand selenium’s metabolism and
significance in biology, toxicology, clinical chemistry and nutrition. This calls for state-of-the-art analytical techniques such as hyphenated
methods that are reviewed with particular emphasis on interfaced separation with element-selective detection and identification of the detected
selenium compounds. Atomic spectral element specific detection for monitoring chromatographic eluent enabled quantitative determination
of selenium species in selenized yeast and qualitative measurement for breath samples. Gas chromatography with atomic emission detection
(AED) of ethylated species and fluoroacid ion pair HPLC applied to the analysis of currently produced or archived selenized yeast and Brassica
juncea have revealed the presence of a previously unrecognised Se–S amino acid, S-(methylseleno)cysteine.
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1. Introduction

∗

Corresponding author. Tel.: +1-413-545-2293;
fax: +1-413-545-4490.
E-mail address: pcuden@chem.umass.edu (P.C. Uden).

Selenium (Se) is an essential element for animals and possibly for plants, but its physiological nature in humans is
ambivalent since it can cause disease by deficiency, but is
toxic at levels relatively close to those required for health.

Analytical speciation is vital because the bioavailability and
toxicity of an element depend on its chemical binding. Geologically, there are no substantive deposits of elemental selenium and it usually occurs in the sulfide ores of heavy
metals deposited as a result of vulcanism and in some coal
deposits. Selenates (SeO4 2− ) are easily leached from soils,
transported to ground waters and most readily taken up by
plants [1]. Selenites (SeO3 2− ) occur in mildly oxidizing neutral pH environments and are less soluble than selenates.
Selenium pollution results from industrial activities such as
oil refineries and coal-burning electric utilities [2]. Comprehensive discussion of environmental selenium is available in
the texts authored by Frankenberger et al. [3,4].
Se accumulates in living tissues, the selenium content of
human blood being about 200 ng/mL, 1000 times greater Se
in surface waters. Biogeochemical cycling of Se in aquatic
systems involves geological erosion and anthropogenic influences. It is incorporated as organoselenium compounds
sequentially through plankton, lower and higher vertebrates
or can be recycled through microorganisms. The chemical
and biochemical transformations involved require analytical
identification and quantification of selenium species at the
highest sensitivity possible. Dimethyl selenide and dimethyl
diselenide have been proposed as primary Se carrier species
[5]. Se-accumulating plants belonging to the families compositae, leguminosae, cruciferae and allium, when grown in
selenium-rich soils, may accumulate Se to concentrations of
several thousands of mg/kg dry mass [6] and may be used
to remove selenium from contaminated soils by phytoremediation [7]. Pyrzynska [8] has reviewed the determination of
selenium species in environmental samples. Concentrations
of selenite and selenate in environmental sea-water, ground
water and fresh water samples have been reported to range
from sub-ng/L in pristine conditions to hundreds of ng/L
in contaminated sources; organoselenium levels have been
found with similar ranges.
Speciation information is needed for the following fields.
The elucidation of biogeochemical transformations of selenium compounds, the identification of natural and anthropogenic compounds with beneficial or detrimental effects,
improvement in species-defined environmental remediation, and increasing knowledge about suitable methods
to prevent or decrease toxicoses in plants, animals and
humans.
Biologically, selenium is not bound by coordination, but
forms covalent C–Se and Se–S bonds, Se-compounds being categorized as enzyme or gene products, although this
distinction is not always complete. The former arises from
enzymatic reactions such as reduction, methylation [9] and
reactions leading to seleno-amino acid synthesis. Selenium
is incorporated into gene products, according to the UGA
codon that encodes for the selenocysteinyl residue [10]. To
elucidate the complexities of selenium chemistry, the determination of total element although essential to determine
element mass balance, provides insufficient information and
must be accompanied by speciation of selenium [11].

Variation in the Se content of animal and vegetable-based
foodstuffs is mainly due to geographical differences in the
amounts and availability of soil Se as transferred to the food
chain. Selenium-deficiency diseases are recognized in parts
of China and elsewhere, but soils rich in Se (e.g. in excess
of 5 ppm) are found in parts of the USA and other regions.
The Se present in most plant-derived foods, notably as selenomethionine (SeMet) and selenocysteine (SeCys) derivatives, tends to have reasonably good bioavailability.
In the early 1970s, a discrete metabolic function was
found for Se as an essential component of the enzyme glutathione peroxidase (GPX) [12] that participates in the antioxidant protection of cells by reducing hydroperoxides.
Several Se-enzymes and selenoproteins are now recognized
[13,14], and have been shown to contain Se in a highly specific form, selenocysteine. The nutritional essentiality of Se
appears to be due to formation of the active selenol group of
such SeCys-proteins, antioxidant protection by the GPXs,
energy metabolism affected by the DIs and redox regulation
of transcriptional factors and gene expression by the TRs.
Desirable Se dietary levels are in a relatively narrow range
of consumption: food containing less than 0.1 mg kg−1
will result in deficiency, whereas levels above 1 mg kg−1
will lead to toxicity. Increasing attention has been paid
to the speciation of Se in common foods. Plants metabolize inorganic Se anions, selenite and selenate to generate
seleno-amino acids such as selenomethionine, selenocysteine, selenocysatathionine and methylselenocysteine. The
allium family whose sulfur chemistry is well-defined exhibit parallel selenium chemistry and high-selenium garlic
has found promise in mammary cancer prevention [15].
At present, no Se-enriched food or nutritional supplements
have been fully characterized with respect to Se-compounds.
This is of great importance since, with no standard of product identity, many different materials may be designated
“Se-enriched” although they contain unknown amounts of
different forms of Se that differ in both biopotency and/or
anti-carcinogenic potential. A widely available selenium
supplement is ‘selenized yeast’, which has been employed
in a number of human nutritional clinical trials [16]. There
is evidence that the pattern of Se-compounds in different
Se-enriched products varies substantially.
Many epidemiological studies have pointed to an inverse
association of Se status and risk to at least some cancers
[17,61]. Most animal studies have shown that supranutritional levels of various Se-compounds can reduce the yields
of tumors caused by chemical or viral carcinogens [17–20].
Clinical intervention trials in the USA [16,21,22] and China
have shown lower cancer risks among subjects taking Se
supplements compared to controls.
Evidence suggests that anti-tumorigenic activities can be
supported by metabolites of forms of the element that naturally occur in foods: the Se-amino acids, SeMet and SeCys,
and methylated Se-compounds such as Se-methyl-SeCys.
With varying efficiencies, these species can be converted
to a number of Se-metabolites, including methylselenol

(CH3 SeH) which appears to be a key anti-tumorigenic
metabolite [23,24] These findings make the consideration
of “Se status” important in the maintenance of overall
health. In so doing, they raise questions about the parameters by which Se status should be defined, and the values of
those parameters that should be taken as appropriate for the
maintenance of good health. If robust analytical methods
can be devised to determine CH3 SeH and/or other critical
Se-metabolites in accessible tissues, then these would be
valuable for monitoring the anti-tumorigenic efficacy of Se.

2. Analytical selenium speciation
Table 1 lists some of the classes and individual selenium
compounds found in environmental and biological systems.
For valid speciation, analytes must be separated in space or
time prior to selenium specific detection. Spacial separation
techniques include radioimmunological assays (RIA) for selenoproteins that offer very low detection limits but require
the proteins to be isolated in amounts sufficient for antibody
production [25]. The time-separated hyphenated techniques
are based on the coupling of electrophoretic or chromatographic separation with an atomic spectrometric or other
selenium specific measurement [11]. This coupling may be
off-line, e.g. SDS-PAGE with instrumental neutron activation analysis (INAA), or on-line, e.g. HPLC–ICP-MS.
The determination of selenium species, including selenoproteins have been reviewed [11,26,27]. The complexity of
analyte matrixes and the typically low level of selenium compounds present even in enriched samples makes speciation
a challenging task but selenium specific detection is a powerful approach. High elemental sensitivity is mandatory, and
quadrupole mass spectrometry with an atmospheric pressure
ionization source, such as the inductively coupled plasma
(ICP) has been successful for HPLC detection [28,29]. Significant isotopic overlap from 40 Ar2 + on the most abundant isotope 80 Se (49.6%) often necessitates monitoring the
less abundant isotopes 82 Se (8.6%) or 77 Se (7.6%). However inter-element isobaric interferences are less pronounced
in HPLC–ICP-MS than for the determination of total sele-

nium. Isobaric interferences that can be partially overcome
with high-resolution mass spectrometers or dynamic reaction cell/collision cell technology.
The low concentrations of the target species represents a
clear challenge; another comes from the need that sample
pretreatment must not change the chemical forms of the target analytes, or must change them in a known and controllable fashion. For example if a 250 mg sample of 1200 mg
Se/kg selenium-enriched yeast is taken up into 5 mL of solution, and target compounds are present at levels of 10% of
the total concentration, then before separation, the concentration of selenium is 6 mg L−1 . If the separation procedure
produces a dilution of 100, the concentration of material after separation is of the order of 60 g/L (60 ppb).

3. HPLC modes for selenium speciation
Reversed-phase, paired ion reversed-phase, ion exchange
and exclusion modes have been employed for selenium speciation. Pedersen and Larsen [29] used a polymer based
strong anion exchange column to resolve selenite, selenate,
selenomethionine and selenocysine at pH 8.5. They added
3% methanol to the mobile phase that enhanced the ICP-MS
signal to give a ca. 1 g/L detection limit for 100 L injections. Gammelgaard et al. [30,31] used anion exchange
chromatography on a Dionex AS11-HC column with 25 mM
NaOH in 2% methanol mobile phase and ICP-MS detection
to determine selenite in human urine after selenomethionine supplementation. Johansson et al. [32] described assisted on-line species conversion hydride generation atomic
absorption spectrometry for speciation of selenate, selenite, selenomethionine and selenocystine in CRM 402 reference material and biological samples. Emteborg et al.
[33,34] quantified selenium species in certified reference
materials by anion exchange with direct injection nebulization ICP-AES and graphite furnace AAS. Sloth and Larsen
showed argon-dimer and other mass interferences at m/z 74,
76, 78 and 80 were reduced by as much as five orders of
magnitude with methane as dynamic reaction cell reactant
for (DRC) ICP-MS [35]. Larsen et al. [36] achieved the

Table 1
Selenium species in environmental and biological systems
Inorganic species
Se(O)-(element), selenide – Se(−II), selenate – SeO4 2− , selenite – SeO3 2−
Simple organic species
Methylselenol (MeSeH), dimethylselenide (Me2 Se), dimethyldiselenide (Me2 Se2 )
trimethylselenonium cation (Me3 Se+ ), dimethylselenone (Me2 SeO2 ), dimethylselenoxide (Me2 SeO), methylseleninic acid anion (MeSe(O)O−
dimethylselenosulfide (MeSSeMe), selenocyanate(SeCN− ,), selenourea (Se=C(NH2 )2
Amino acids and low molecular mass species
Selenomethionine, selenocysteine, selenocystine, Se-methylselenocysteine, selenocysteic acid, Se-methylselenomethionine, S-(methylseleno)cysteine,
selenomethionine selenoxide hydrate, selenohomocysteine, ␥-glutamyl-Se-methylselenocysteine, Se-adenosylselenohomocysteine, selenocholine,
selenobetaine, selenoglutathione
Other compounds
Selenopeptides, selenoproteins, selenoenzymes, selenosugars, Se-metal metallothionines

ICP-MS using semi-preparative reversed-phase columns for
two-dimensional HPLC. Montes-Bayon et al. [42] speciated
wild-type and genetically modified selenium-accumulating
Brassica juncea with HPLC–ICP-MS and ES-MS detection
and found a high preponderance of Se-methylselenocysteine
being in the modified sample.
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Fig. 1. Se-specific HPLC–ICP-MS chromatograms using (A) 0.1% TFA
ion pairing agent and (B) 0.1% HFBA ion pairing agent. (1): Selenous acid
(selenite); (2): selenic acid (selenate); (4): methylseleninic acid (methylseleninate); (5): selenolanthionine; (6): trimethyl selenonium cation; (7): selenocystine; (8): selenocystathionine; (9): Se-methylselenocysteine; (10):
Se-2-propylylselenocysteine; (11): selenomethionine; (12): unknown; (13):
␥-glutamyl-Se-methylselenocysteine; (14): Se-allylselenocysteine [40].

most comprehensive ion exchange separation of selenium
species yet reported; cations were separated on a cation exchange column at pH 3 with a gradient of pyridinium formate and anions on an anion exchange column at pH 8.5 with
a Tris salicylate mobile phase. Selenomethionine-Se-oxide
was observed in selenized yeast and dimethylselenonium
propionate (DMSeP) in an algal extract.
Selenoamino acids are too hydrophilic to be retained
and separated with typical C8 and C18 reversed-phase column conditions, but retention and separation is increased
by using ion pairing reagents such as trifluoroacetic acid
(TFA) [28,37] or octane sulfonic acid [38]. Perfluorinated
carboxylic acids give better resolution and are effective for
characterizing samples containing many different classes of
organoselenium compounds [39,40]. Heptafluorobutanoic
acid (HFBA) provides considerable resolution enhancement over TFA and allows separation of many additional
organoselenium species (Fig. 1) [40]. The method also can
determine the presence of selenoxides and organoanions.
pH control at 2.0–2.5 enable cations such as trimethylselenonium and protonated seleno-amino acids and selenoxides to be resolved. Anionic species show some retention
as protonated forms retained by reversed phase partition. McSheehey et al. [41] isolated fractions of selenized
yeast extracts for on-line and off-line investigations by

Lobinski et al. [26] have summarized applications of
HPLC with selenium-specific detection for the analysis of
biological samples with respect to column type, mobile
phase and detection modes. Resolution of small compounds
of similar molecular mass may be achieved in addition
to the possibility of the detection of selenoproteins [43].
SEC–ICP-MS has had limited success for selenoproteins,
the large dilution factor for Se limiting sensitivity in attempts
to speciate glutathione peroxidase. SEC–HPLC was the first
procedure to measure selenoprotein-P in human plasma, but
it lacks the resolution and sensitivity for separation of the
major Se-proteins. A human serum sample yielded three
signals, but none co-eluted with the glutathione peroxidase activity [44]. Speciation of human breast milk whey
gave four Se signals for apparent molecular weights of 15,
60, 1500 and >2000 kDa [45]. A combination of affinity
chromatography with SEC–ICP-MS separated three major
Se-containing proteins (albumin, glutathione peroxidase
and selenoprotein-P) in human plasma [46].
Suzuki et al. [47,48] used HPLC–ICP-MS with 82 Se to
study speciation of both endogenous and enriched selenium
species. Selenium incorporation into cyanobacterial metallothionein induced under heavy metal stress was studied
using SEC–ICP-MS, two pathways being indicated [49].
Selenite and selenate metabolism in rats was investigated
[50] and exchange of endogenous and dietary selenium
examined in brain, liver and kidney [51].

5. Chiral selenium speciation by HPLC–ICP-MS
The presence of asymmetric carbons in ␣-seleno-amino
acids and related compounds produces chiral enantiomers
with differing physiological activities. HPLC enantiomer
separation is possible with various chiral stationary phases.
Mendez et al. [52,53] speciated D and L selenomethionine isomers in yeast and parenteral solutions with a
␣-cyclodextrin stationary phase and also employed a
teicoplanin-based chiral phase [54]. Sanz Medel and Gonzalez [55] compared hybrid chiral methodologies based on gas
chromatography (GC), HPLC and capillary electrophoresis,
coupled with ICP-MS. Sutton et al. [56] speciated enantiomers of D,L-selenocystine, D,L-selenomethionine and
D,L-selenoethionine using a chiral crown ether stationary
phase and examined a range of commercial dietary supple-

ments with ICP-MS detection. Ponce de Leon et al. [57] used
this phase to separate nine seleno-amino acids in selenium
enriched onion, were analyzed and some of the seleno-amino
acid enantiomers were identified. Montes-Bayon et al.
[58] used 1-fluoro-2,4-dinitrophenyl-5-L alanine amide
to derivatize enantiomers of selenoamides for enhanced
resolution.

6. GC microwave plasma atomic-emission detection
(GC–AED)
Gas chromatography interfaced with atomic plasma emission spectroscopic detection (GC–AED) [59] has been used
to detect and determine volatile organoselenium compounds
present in or produced by plants. Headspace-GC–AED was
used to detect selenium compounds in members of the
Allium family such as garlic, elephant garlic, onion and
broccoli (Brassica) [60]. Natural abundance organoselenium compounds in human breath after ingestion of garlic
were identified using Tenax trap/cryogenic-GC–AED [61].
Calle-Guntinas et al. [62] reported absolute detection limits
of 10 pg for dimethylselenide.
Free seleno-amino acids in normal and selenium-enriched
samples have been determined by GC–AED of ethylated
derivatives [61]. Calle-Guntinas et al. [63] compared AED,
flame photometry and GC-MS detection for selective determination of selenomethionine in wheat samples.
Selenomethionine is the predominant seleno-amino acid
in plants but selenocysteine is probably formed from glycine
and selenite in mammalian tissues. Analytical approaches
are typically based on degradation of the original matrix
[39]. GC–AED and GC–MS provide a valuable alternative analytical approach to HPLC with good sensitivity.
Seleno-amino acids have been derivatized with isopropylchloroformate and bis (p-methoxyphenyl) selenoxide [64],
and with ethyl chloroformate [60,65]. Recent results from
such investigations are described later. An alternative approach for selenomethionine involves quantitative formation
of volatile methylselenocyanide with CNBr [66].

7. GC with ICP-MS detection
Mendez et al. [54] separated selenomethionine enantiomers as trifluoroacetyl-O-isopropyl derivatives by capillary GC–ICP-MS with a 1-valine-tert-butylamide modified
chiral stationary phase, obtaining detection limits below
250 pg for each isomer. Bayon et al. [67] used a glow
discharge (rf-GD) mass spectral ion source as a sample
introductory technique for seleno-amino acids, detecting
100 pg of derivatized selenomethionine. Vonderheide et al.
[68] used solid phase microextraction (SPME) for sample
preparation followed by isopropylchloroformate derivatization for GC–ICP-MS obtaining sub-ppb detection limits.

8. Capillary zone electrophoresis (CZE) with ICP-MS
detection
CZE can afford a high separatory efficiency and the possibility of analyzing for relatively labile species because of
the absence of chromatographic packing, but ultrasensitive
element-selective detection, such as high-resolution ICP-MS
is needed because of the small sample amount injected. A
commercial interface for CZE–ICP-MS is available which
optimizes electrophoretic and nebulizer flows and has minimal dilution and sample consumption [69].
Michalke and coworkers [70–72] have identified and
determined selenate-carrying glutathione (GSSeSG) and
differentiated methionine, selenomethionine, cystamine and
selenocystamine selenate and selenite in milk with speciation at the 10–50 g/SeL−1 level. Mounicou et al. [73]
used a two-dimensional separation approach for selenized
yeast speciation, based on size exclusion followed by
CZE–ICP-MS, coupling to the ICP via a self-aspirating total
consumption nebulizer. Detection limits of low molecular
weight selenium species were in the range 7–18 g/L, but
problems were encountered with recovery of high molecular
weight Se-species from the CZE capillary.

9. Identification of selenium species
HPLC–ICP-MS, GC–AED and CZE–ICP-MS have adequate sensitivity and selenium selectivity for selenium
speciation in many samples but provide no structural identification. This lack becomes more problematic as more
efficient separations are achieved. Chromatographic identification may be based on migration/retention time, but authentic standards of selenium compounds are often not available
for retention-based identification. Approaches to analyte
authentication involve preparation of additional synthetic
standards or isolation of purified selenium compounds from
sample matrixes followed by further characterization; e.g.
by electrospray (ES-MS) [40,74,75,76] or matrix-assisted
laser desorption ionization (MALDI-MS) [77].
Fan et al. [75] synthesized: Se-methylselenomethionine,
Se-methylselenocysteine and dimethylselenonium propionate, and employed a combination of two-dimensional
multinuclear NMR, electrospray MS and GC–MS methods
to identify Se- GC–MS is sensitive but restricted to volatilizable species; for the non-volatilizable metabolites, there is
often a discrepancy between the sensitivity of HPLC–MS
techniques and that needed for speciation in real samples.
Purification and preconcentration of Se-species is usually
needed.
Higher resolution MS techniques such as ESI-triple
quadrupole MS, ESI-MALDI-TOF and ESI-QTOF provide
high precision and exact mass determination. ESI MS has
been applied to preparations of Se-methylselenomethionine,
Se-methylselenocysteine and dimethylselenonium propionate (precursors of volatile alkylselenides) [74].
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The value of applying parallel analytical separation and
characterization procedures to validate more completely
both qualitative and quantitative elemental speciation is
clear, particularly when analytes are in low concentration
and in complex matrixes. As discussed earlier, the use of gas
chromatographic and liquid chromatographic separations
can provide substantially more information and analytical
credibility than can gained by either technique in isolation.
Indeed such an approach represents good general analytical
practice.
At present, despite substantial efforts, no Se-containing
plant or animal components have been fully speciated nor
have Se-enriched food or nutritional supplements have been
fully characterized with respect to Se-compounds. There
is evidence that the pattern of Se-compounds in different Se-enriched products varies substantially. While major
Se-containing components have frequently been identified,
typical quantitative selenium mass balance is incomplete
when compared with total selenium content. Indeed ‘minor’
Se-compounds may prove to be critical in both biopotency
and anti-carcinogenic potential This is of great importance
since, with no standard of product identity, many different
materials may be designated “Se-enriched” although they
contain differing unknown amounts of different forms of
Se. A widely available selenium supplement is ’selenized
yeast’, that has been employed in a number of human
nutritional clinical trials [16]. Se speciation can vary substantially in such material.
The complexity of the selenium speciation profile is exemplified for a selenium-enriched yeast in Fig. 2. Heptafluorobutanoic acid paired ion reverse phase separation and
ICP-MS detection were employed as in [40]. The chromatogram is displayed at both low and high (×25) sensitivity
to emphasize both major components (in this case selenomethionine and selenomethionine selenoxide hydrate) but also
to show the high complexity of minor (mostly unidentified)
selenium species. From the standpoint of speciation of se-
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Pneumatically assisted ESI MS was used to identify
Se-adenosylhomocysteine in an extract of selenized yeast
[78]. Kotrebai et al. [40,76] synthesized a number of
seleno-amino acids and matched their retention times with
signals produced by extracts of yeast supplements and garlic
and plant extracts. McSheehy et al. [79,80] speciated selenium in garlic and yeast by parallel ICP-MS and electrospray
tandem MS and by three-dimensional SEC–CZE–ICP-MS.
Ogra et al. [81] identified a novel selenium metabolite, the
selenosugar diasteriomer Se-methyl-N-acetylhexosamine in
rat urine, by this method. Encinar et al. [82,83] identified
water-soluble and triptic digests of yeast selenoproteins
by HPLC–ICP-MS followed by MALDI-TOF and Q-TOF
mass spectrometry.
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Fig. 2. Se-specific HPLC-ICP-MS chromatograms of enzymatic hydrolysis
of 1250 ppm Se-enriched yeast using 0.1% HFBA ion pairing agent (right
scale expanded).

lenium compounds with respect to nutritional and biological activity it is an open question whether essential human
selenium uptake is species dependent. In commercial nutritional supplements such as high selenium-enriched yeast
selenomethionine or selenite are alternatively the major selenium species present. In the ‘Clark trial’ the former supplementation mode was used [16].
As was noted above, such species can be converted to
various Se-metabolites, including methylselenol (CH3 SeH)
which appears to be a key anti-tumorigenic metabolite
[23,24]. The question of whether other ‘more potent’ selenium compounds albeit present at lower levels in foods
or nutritional supplements may be responsible for bionutritional activity depends on the prior identification of these
‘compounds.
We have recently noted the presence of a previously unrecognized seleno-amino acid, S-(methylseleno)cysteine, that
is present in selenium-enriched yeast that has been stored
for a considerable time or subjected to elevated temperature. Selenium speciation by complementary GC–AED and
HPLC–ICP-MS has proved particularly useful in identifying
this Se–S species. [84,85]. The former technique has the distinct advantage of simultaneous detection of S and Se in the
same chromatogram. Fig. 3 shows segments of selenium and
sulfur capillary gas chromatograms of seleno-amino acids
and analagous sulfur acids respectively, derivatized by ethyl
chloroformate. GC–AED equipment and conditions are as
reported previously [84]. Fig. 4 depicts selenium specific
GC–AED of ethylated enzymatic hydrolyzates of supplemental enriched yeast tablets both as employed and archived
from the ‘Clark trial’ and as presently manufactured. The
profiles for the yeast tablets are virtually identical to those
seen also for the free yeast powder and the species, identified as S-(methylseleno)cysteine is evident [84]. This important observation suggests that the nutritional tablet format
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Fig. 3. Se-specific GC–AED chromatograms of ethylated amino acids.
(A) seleno-amino acids: (1) Se-methylselenocysteine derivative; (2)
selenomethionine derivative; (3) Se-allylselenocysteine derivative; (4)
Se-propylselenocysteine derivative; (5) selenoethionine derivative; (6) selenocysteine derivative. (B) sulfuramino acids: (A) methionine derivative;
(B) ethionine derivative; (C) cysteine derivative.
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Fig. 5. Se-specific GC–AED chromatograms of ethylated amino acids
from: (A) selenium enriched yeast; (B) selenite treated. B. juncea shoots.

retains the same speciation as the constituent yeast despite
the presence of formulation excipients.
B. juncea is a selenium-accumulating plant that has
received speciation attention, for example genetically modified plants being found to contain Se-methylselenocysteine
[42]. In the course of a study of the effect of selenite
or selenate on the Se speciation of B. juncea the presence of S-(methylseleno)cysteine has also been seen.
Fig. 5 shows comparative GC–AED chromatograms of
ethylated enzymatic extracts of a typical standard reference selenized yeast which does contain a small amount
of S-(methylseleno)cysteine, and B. juncea shoots grown
in a selenite growth medium. In which the Se–S acid
appears at a higher relative level to selenomethionine. Se-methylselenocysteine is not apparent in these
shoots. Fig. 6 shows a parallel HPLC–ICP-MS chromatogram. In view of this observation in this case,
S-(methylseleno)cysteine may be present in different natural or enriched selenium materials. Studies as to whether
this compound has nutritional of biological function are
appropriate.
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Fig. 4. Se-specific GC–AED temperature programmed chromatograms
(Se 196 nm) of ethylated enzymatic hydrolyzates of archived (Clark trial
[16]) 200 g Se tablets (top), reference 200 g Se tablets (center), and
selenomethionine (bottom). Peak at ca.36 min contains sulfur.

11. Anticipated developments
Problems in speciation of environmentally and biologically important organoselenium compounds remain challenging. Much has been achieved in terms of the detection
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in complex matrices, but the very low analyte levels often make the identifications problematic. The wider use
of techniques that give direct access to structural information such as NMR and high-resolution mass spectrometry
is important. The classical approach of concentration, purification and isolation of the seleno species detected can
overcome the marginal sensitivity and vulnerability to
matrix interferences that is often experienced with these
techniques. Specific chemical derivative transformation of
analyte compounds is a powerful approach that nevertheless
requires careful control if speciation is not to be changed.
More definitive results are needed such that barriers to
a molecular-level understanding of Se clinical chemistry,
ecotoxicology and nutrition can be eliminated.
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